REDCARE PHARMACY NV |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 130 EUR | 0.00% |
|
+0.78% | -1.22% |
| 04-26 | REDCARE PHARMACY : Deutsche Bank reiterates its Buy rating | ZD |
| 04-26 | REDCARE PHARMACY : Hauck & Aufhauser keeps its Buy rating | ZD |
| Sales 2024 * | 2.38B 2.54B 204B | Sales 2025 * | 2.91B 3.11B 249B | Capitalization | 2.63B 2.81B 225B |
|---|---|---|---|---|---|
| Net income 2024 * | -8M -8.55M -685M | Net income 2025 * | 45M 48.11M 3.85B | EV / Sales 2024 * | 1.17 x |
| Net Debt 2024 * | 154M 164M 13.14B | Net Debt 2025 * | 135M 144M 11.56B | EV / Sales 2025 * | 0.95 x |
| P/E ratio 2024 * |
-261
x | P/E ratio 2025 * |
67.8
x | Employees | 1,900 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.87% |
More Fundamentals
* Assessed data
More news
Latest transcript on Redcare Pharmacy NV
More recommendations
More press releases
More news
| 1 week | +0.78% | ||
| Current month | -14.28% | ||
| 1 month | -7.83% | ||
| 3 months | -1.81% | ||
| 6 months | +16.96% | ||
| Current year | -1.22% |
1 week
125.50
142.30
1 month
125.50153.00
Current year
118.05153.00
1 year
81.64153.00
3 years
36.51189.00
5 years
28.30249.00
10 years
24.00249.00
| Managers | Title | Age | Since |
|---|---|---|---|
Olaf Heinrich
CEO | Chief Executive Officer | 54 | 31/07/23 |
Jasper Eenhorst
DFI | Director of Finance/CFO | 51 | 31/01/20 |
Theresa Holler
COO | Chief Operating Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Björn H. Söder
CHM | Chairman | 52 | 31/12/15 |
Frank Köhler
FOU | Founder | 60 | 31/12/00 |
| Director/Board Member | 53 | 13/04/22 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.46% | 17 M€ | -.--% | - | |
| 0.02% | 773 M€ | -.--% | - | |
| 0.01% | 10 M€ | -3.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 130 | 0.00% | 115,616 |
| 25/04/24 | 130 | -3.92% | 170,092 |
| 24/04/24 | 135.3 | +0.22% | 108,909 |
| 23/04/24 | 135 | +3.05% | 98,781 |
| 22/04/24 | 131 | +1.55% | 47,526 |
Delayed Quote Xetra, April 26, 2024 at 04:35 pm
More quotes
Redcare Pharmacy NV is a company based in the Netherlands that retails pharmaceutical products online. The Company focuses on non-prescription medication (OTC), as well as on pharmacy-related beauty and personal care (BPC) products. The Company is active in Belgium, Spain, Italy, France, Austria, the Netherlands and Germany.
Sector
Drug Retailers
Calendar
29/07/2024
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
130
EUR
Average target price
155.2
EUR
Spread / Average Target
+19.37%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -1.22% | 2.8B | |
| -31.97% | 10.84B | |
| +8.14% | 6.04B | |
| -11.41% | 5.86B | |
| -30.42% | 6.06B | |
| -0.88% | 4.71B | |
| +52.19% | 4.29B | |
| -12.31% | 3.61B | |
| -14.86% | 3.33B | |
| -6.93% | 3.01B |
- Stock Market
- Equities
- RDC Stock
